NMC
INZY
NEA Management Company’s Inozyme Pharma INZY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.75M | Hold |
2,437,689
| – | – | 0.73% | 21 |
|
|
2025
Q1 | $2.22M | Hold |
2,437,689
| – | – | 0.17% | 31 |
|
|
2024
Q4 | $6.75M | Hold |
2,437,689
| – | – | 0.38% | 31 |
|
|
2024
Q3 | $12.7M | Hold |
2,437,689
| – | – | 0.69% | 24 |
|
|
2024
Q2 | $10.9M | Hold |
2,437,689
| – | – | 0.82% | 23 |
|
|
2024
Q1 | $18.7M | Hold |
2,437,689
| – | – | 1.16% | 23 |
|
|
2023
Q4 | $10.4M | Hold |
2,437,689
| – | – | 0.69% | 29 |
|
|
2023
Q3 | $10.2M | Hold |
2,437,689
| – | – | 0.79% | 27 |
|
|
2023
Q2 | $13.6M | Hold |
2,437,689
| – | – | 1.04% | 24 |
|
|
2023
Q1 | $14M | Hold |
2,437,689
| – | – | 0.97% | 25 |
|
|
2022
Q4 | $2.56M | Sell |
2,437,689
-6,690
| -0.3% | -$7.03K | 0.14% | 46 |
|
|
2022
Q3 | $6.55M | Hold |
2,444,379
| – | – | 0.33% | 39 |
|
|
2022
Q2 | $10.5M | Hold |
2,444,379
| – | – | 0.54% | 34 |
|
|
2022
Q1 | $10M | Hold |
2,444,379
| – | – | 0.29% | 42 |
|
|
2021
Q4 | $16.7M | Hold |
2,444,379
| – | – | 0.34% | 36 |
|
|
2021
Q3 | $28.3M | Hold |
2,444,379
| – | – | 0.34% | 28 |
|
|
2021
Q2 | $41.7M | Hold |
2,444,379
| – | – | 0.54% | 28 |
|
|
2021
Q1 | $48.4M | Hold |
2,444,379
| – | – | 1.09% | 23 |
|
|
2020
Q4 | $50.5M | Hold |
2,444,379
| – | – | 1.33% | 21 |
|
|
2020
Q3 | $64.3M | Buy |
+2,444,379
| New | +$64.3M | 2.72% | 17 |
|